CDMRP Tuberous Sclerosis Complex Research Program: Clinical Translational Research Award

The Clinical Translational Research Award supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of TSC.

Projects supported by this award mechanism may include, but not limited to:

• Studies moving from preclinical to clinical research and/or the reverse, analyzing human anatomical substances and/or data associated with completed clinical trials (such as correlative studies that investigate the correlation of a set of genetic and/or environmental factors with disease progression, or the effect of an intervention on the disease outcomes, etc.)
• Studies advancing clinical trial readiness through development of biomarkers, clinical endpoints, and validation of pharmacokinetics/pharmacodynamics.
• Pilot clinical trials where limited clinical testing (e.g., small sample size) of a novel intervention is necessary to inform the next step in the continuum of translational research.

Projects that are exploratory and/or strictly animal research will not be considered for funding.

It is expected that 2 awards will be granted. 

Funding: $1,000,000 total
Duration: 3 years

Research Authority due date: 23.6.22

Pre application (required) due date: 30.6.22

Full application due date: 28.7.22